Name: BioNTech vaccine heads to EU as effectiveness against new strain tested
Uploaded: 2020-12-25T18:15:04.000Z
Duration: 1 min 36 s
Description: Thousands of YouTube videos with English-Chinese subtitles! Now you can learn to understand native speakers, expand your vocabulary, and improve your pronunciation...

by on Tech said on Tuesday the covert 19 vaccine it developed with Pfizer should still be effective against the newly discovered variant of the virus circulating in the U.

K Chief Executive Ugur Sahin said the company is testing whether the vaccine works to protect against the mutation on expects results in the next two weeks.

It has nine mutations, not only a single mutations and we don't know at the moment if our vaccine is also able toe provide protection against this new variant.

But scientifically, it is highly likely that the immune response by this vaccine also also can deal with the new virus virus variants, Sahin confirmed.

MAWR vaccine results about asymptomatic transmission are also on the way.

We expect that end off January or in February.

We will be able able toe update, update and provide information with the vaccine.

Vaccine is able to prevent a symptomatic infection by on Tech is preparing to send 12.5 million doses to EU countries by the end of the year.

After approval from Brussels on Monday This week, countries across the globe shut their borders to Britain, causing travel chaos on raising the prospect of food shortages.

 The World Health Organization has also cautioned against major alarm from the variant, saying this was a normal part of the pandemics evolution. 

Subtitles ListPlay Video

BioNTech vaccine heads to EU as effectiveness against new strain tested

immune

effective

chaos

executive